Divis Laboratories benefits from strong CDMO demand but faces high valuations, prompting a hold recommendation for investors.
First-quarter earnings reports eased concerns about a potential artificial intelligence bubble, particularly as tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results